tiprankstipranks
Trending News
More News >
AnaptysBio Inc (ANAB)
NASDAQ:ANAB

AnaptysBio (ANAB) Similar Stocks

Compare
624 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
AnaptysBio
$43.80
$1.23B
96.46%
9 Buy
1 Hold
0 Sell
Strong Buy
Meiragtx Holdings
$8.44
$697.05M
34.03%
6 Buy
0 Hold
0 Sell
Strong Buy
Keros Therapeutics
$21.53
$649.54M
13.96
-67.06%
3 Buy
4 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$5.14
$953.34M
194.94%
6 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$26.58
$2.23B
218.26%
8 Buy
0 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$42.57
$3.62B
565.82%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANAB
AnaptysBio
44.95
29.44
189.81%
MGTX
Meiragtx Holdings
8.39
2.24
36.42%
KROS
Keros Therapeutics
21.84
-46.81
-68.19%
CMPX
Compass Therapeutics
5.25
3.58
214.37%
OLMA
Olema Pharmaceuticals
30.68
22.27
264.80%
TERN
Terns Pharmaceuticals
44.61
37.91
565.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts